84-4047-29 Mitogen-activated Protein kinase 7 (MAPK7) 50ul 324030
特徴
- Plays a role in various cellular processes such as proliferation, differentiation and cell survival.
- The upstream activator of MAPK7 is the MAPK kinase MAP2K5.
- Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C.
- EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway.
- May have a role in muscle cell differentiation.
- May be important for endothelial function and maintenance of blood vessel integrity.
- MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways.
- Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression.
- Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction.
- Applications:Suitable for use in ELISA and Immunohistochemistry.
- Other applications not tested.
- Recommended Dilution:Immunohistochemistry: 1:20-1:200Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:50ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
- Specificity:Human
- Isotype:IgG
- Calc Applications Abbrev:E IHC
- Calc Crossreactivity:Hu
- Immunogen:Recombinant human Mitogen-activated protein kinase 7 protein (aa1-310).
- Shelf Life:1year
- Swiss Prot Number:Q13164
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]